Clover Health Securities Litigation Settlement
This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Clover Health and individual defendants allegedly made false and misleading statements about legal violations, regulatory investigations, sources of growth, use of proprietary software, GAAP compliance, and SEC Regulation S-K compliance. The defendants have agreed to settle these federal securities law claims for $22 million.
Do you qualify?
All persons or entities who purchased or acquired Clover securities (including warrants) between October 6, 2020, and February 3, 2021, inclusive. Excluded are Clover, individual defendants, officers, directors, and those who properly request exclusion.
How to file
Contact the Claims Administrator at 1-877-381-0387 or info@CloverHealthSecuritiesLitigation.com for the Claim Form and submission instructions. Distribution of payments to eligible claimants has commenced as of August 5, 2024.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
Estée Lauder Securities Settlement
Estée Lauder is settling securities litigation relating to alleged damages to investors who purchased or acquired publicly traded common stock of The Estée Lauder Companies Inc. during the class period. The defendant has not admitted wrongdoing in this settlement.
E-Commerce China Dangdang Securities Settlement
E-Commerce China Dangdang, Inc. was involved in a take-private transaction (merger) that closed on September 20, 2016. Shareholders who held American Depositary Shares during the Class Period claim they were harmed by undisclosed information related to the Company's take-private transaction. The defendant has agreed to settle these securities claims without admitting wrongdoing.
Evolv Technologies Holdings Securities Settlement
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.